MARSHALL WACE ASIA Ltd decreased its stake in Equifax, Inc. (NYSE:EFX) by 27.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 211,001 shares of the credit services provider’s stock after selling 78,598 shares during the period. MARSHALL WACE ASIA Ltd owned about 0.18% of Equifax worth $28,907,000 as of its most recent filing with the SEC.
Several other large investors have also recently added to or reduced their stakes in the company. YorkBridge Wealth Partners LLC boosted its stake in Equifax by 23.8% in the first quarter. YorkBridge Wealth Partners LLC now owns 744 shares of the credit services provider’s stock valued at $102,000 after buying an additional 143 shares during the period. IFP Advisors Inc boosted its stake in Equifax by 9.4% in the first quarter. IFP Advisors Inc now owns 745 shares of the credit services provider’s stock valued at $102,000 after buying an additional 64 shares during the period. Park Avenue Securities LLC purchased a new stake in Equifax during the second quarter valued at about $201,000. Wilbanks Smith & Thomas Asset Management LLC purchased a new stake in Equifax during the first quarter valued at about $202,000. Finally, Edgewood Management LLC purchased a new stake in Equifax during the first quarter valued at about $205,000. 89.63% of the stock is owned by institutional investors and hedge funds.
Equifax, Inc. (EFX) traded down 0.07% on Tuesday, reaching $139.74. 21,028 shares of the company’s stock were exchanged. Equifax, Inc. has a 1-year low of $110.87 and a 1-year high of $147.02. The firm has a market capitalization of $16.82 billion, a price-to-earnings ratio of 29.60 and a beta of 0.91. The stock’s 50 day moving average price is $142.15 and its 200 day moving average price is $136.87.
Equifax (NYSE:EFX) last posted its quarterly earnings results on Wednesday, July 26th. The credit services provider reported $1.60 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.57 by $0.03. Equifax had a net margin of 17.44% and a return on equity of 24.88%. The company had revenue of $856.70 million for the quarter, compared to the consensus estimate of $860.48 million. During the same period last year, the firm posted $1.43 EPS. The company’s revenue for the quarter was up 5.6% on a year-over-year basis. On average, analysts expect that Equifax, Inc. will post $6.08 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Friday, August 25th will be issued a $0.39 dividend. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.12%. Equifax’s dividend payout ratio (DPR) is presently 33.05%.
COPYRIGHT VIOLATION WARNING: “Equifax, Inc. (EFX) Stake Decreased by MARSHALL WACE ASIA Ltd” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another site, it was illegally copied and republished in violation of U.S. & international copyright & trademark legislation. The correct version of this news story can be read at https://stocknewstimes.com/2017/08/22/equifax-inc-efx-stake-decreased-by-marshall-wace-asia-ltd.html.
A number of brokerages recently weighed in on EFX. Stephens cut shares of Equifax from an “overweight” rating to an “equal weight” rating in a research report on Friday, April 28th. Deutsche Bank AG reissued a “buy” rating and issued a $160.00 price target (up from $140.00) on shares of Equifax in a research report on Thursday, July 27th. BidaskClub raised shares of Equifax from a “hold” rating to a “buy” rating in a research report on Saturday, June 17th. Royal Bank Of Canada reissued a “buy” rating on shares of Equifax in a research report on Wednesday, August 9th. Finally, Argus began coverage on shares of Equifax in a research report on Tuesday, June 13th. They issued a “buy” rating and a $166.00 price target for the company. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eight have issued a buy rating to the company’s stock. Equifax currently has an average rating of “Buy” and a consensus price target of $145.45.
In related news, insider Joseph Michael Loughran III sold 4,000 shares of the stock in a transaction dated Tuesday, August 1st. The shares were sold at an average price of $146.02, for a total value of $584,080.00. Following the sale, the insider now owns 42,723 shares of the company’s stock, valued at approximately $6,238,412.46. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO John W. Gamble, Jr. sold 6,500 shares of the stock in a transaction dated Tuesday, August 1st. The stock was sold at an average price of $145.60, for a total transaction of $946,400.00. Following the completion of the sale, the chief financial officer now directly owns 42,078 shares in the company, valued at approximately $6,126,556.80. The disclosure for this sale can be found here. In the last ninety days, insiders sold 12,219 shares of company stock worth $1,780,938. Corporate insiders own 1.29% of the company’s stock.
Equifax Company Profile
Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.
Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX).
Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
